Statement Of Cash Flows [Abstract]

Biocartis Group NV - Filing #3122958

Concept 2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for finance income (cost)
17,690,000 EUR
8,411,000 EUR
Adjustments for increase (decrease) in deferred income including contract liabilities [abstract]
Adjustments for increase (decrease) in deferred income including contract liabilities
791,000 EUR
494,000 EUR
Adjustments for increase (decrease) in employee benefit liabilities
143,000 EUR
69,000 EUR
Adjustments for undistributed profits of investments accounted for using equity method
884,000 EUR
659,000 EUR
Income taxes paid, classified as operating activities
2,000 EUR
2,000 EUR
Cash flows from (used in) investing activities [abstract]
Purchase of financial instruments, classified as investing activities
2,500,000 EUR
Cash flows from (used in) financing activities [abstract]
Payments for debt issue costs
10,782,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.